Bixiye
QP4-18 Remember to Request Subscriber ID Cards
Taariikhda uu dhaqangalayo Barnaamijka: Jan 16, 2018
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2911 - 2920 ee natiijooyinka 3167
Bixiye
P2-18 New Medical Drug PA Requirements for Voretigene Neparvovec (Luxturna)
Taariikhda uu dhaqangalayo Barnaamijka: Jan 11, 2018
Bixiye
P1-18 New Drugs, Aimovig (erenumab), Fremanezumab and Galcanezumab Will Require PA
Taariikhda uu dhaqangalayo Barnaamijka: Jan 09, 2018
Bixiye
QP3-18 Pharmacy Benefit Update - Helixate FS Will No Longer Be Covered
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2018
Bixiye
QP2-18 Pharmacy Benefit Exclusion for Luxturna
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2018
Bixiye
QP1-18 Transition of Care Management Features for New Medicare Advantage Prescription Drug Plans
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2018
Bixiye
2017 December Provider Press
Taariikhda uu dhaqangalayo Barnaamijka: Des 29, 2017
Bixiye
P82-17 Commercial Prior Authorization Requirement for Outpatient Services for Occupational Therapy, Physical Therapy and Speech Therapy
Taariikhda uu dhaqangalayo Barnaamijka: Des 13, 2017
Bixiye
P83-17 Clarification to MHCP Prior Authorization Requirements for Nusinersen (Spinraza)
Taariikhda uu dhaqangalayo Barnaamijka: Des 13, 2017
Bixiye
P80-17 New Drug-Related PA with QL Criteria: Bonjesta, Diclegis
Taariikhda uu dhaqangalayo Barnaamijka: Des 12, 2017